Reduced Cholecystokinin Levels in Cerebrospinal Fluid of Parkinsonian and Schizophrenic Patients Effect of Ceruletide in Schizophreniaa
- 1 July 1985
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 448 (1) , 507-517
- https://doi.org/10.1111/j.1749-6632.1985.tb29944.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disordersLife Sciences, 1984
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983
- Peptides and the blood-brain barrierLife Sciences, 1983
- CCK nerve terminals in the rat striatal and limbic areas originate partly in the brain stem and partly in telencephalic structuresLife Sciences, 1983
- Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8)Peptides, 1982
- Origin of the Cholecystokinin-Containing Fibers in the Rat CaudatoputamenScience, 1982
- Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the RatScience, 1981
- Differential cataleptogenic and antistereotypic effects of caerulein and haloperidolNeuropharmacology, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- SCHIZOPHRENIA AND THE LIMBIC SYSTEMThe Lancet, 1974